Responsible supply. A public record.
NEUVIOR Pharmaceuticals Ltd publishes a voluntary Modern Slavery Assessment and Statement. The signed document remains the authoritative policy record. This redesigned reading page and companion guide make its scope, expectations and approval easier to find without changing the signed wording.
The 2026 signed statement.
The retained 11-page statement is effective 10 April 2026 and covers 4 August 2025 to 10 April 2026. It visibly records an electronic signature by Varun Sharma, Director, dated 17 July 2026 at 16:29 BST. The original has been preserved unchanged during this design refresh.
An approach proportionate to the company.
The record describes an early-stage life-sciences company with an evolving third-party supplier base. It considers scientific services, physical goods, logistics, support services and professional or digital suppliers. It recognises that risk can rise as future manufacturing, packaging and distribution relationships develop.
The statement records a voluntary publication basis and the company’s position that it was below the Section 54 turnover threshold. That company-reported position should be reassessed as the business changes. It is not a third-party turnover audit or a blanket exemption from supplier requirements.
Policies that protect workers.
The signed record sets out a zero-tolerance position, ethical recruitment expectations, worker protections, supplier standards and a route for escalation. Its risk approach considers geography, workforce model, subcontracting and the service being supplied. Small spend does not automatically mean low risk.
Supplier review should be proportionate to those risks. The documented approach includes screening, information requests, deeper examination where needed, contractual controls and ongoing review. The policy prioritises worker safety and the consequences of remediation decisions.
Commitments need implementation records.
Training expectations, effectiveness measures and review commitments are described in the signed statement. Their implementation needs separate evidence. This website does not turn those commitments into invented attendance figures, supplier-screening percentages or a claim that no incidents have occurred.
For a buyer or collaborator, the useful follow-up is specific: which relationship or activity is in scope, who owns it and what record supports the relevant commitment? A signed policy is a starting point for that discussion, rather than a certification of every supplier.
A designed guide. The same signed authority.
The new reader’s companion summarises the six disclosure areas, explains how suppliers and buyers can use the record and connects it with the current NHS context. It is clearly marked as a review draft. It does not renew approval, replace the statement, create a new reporting channel or re-sign on the director’s behalf.
Evergreen and NHS procurement.
The current NHS Evergreen matrix includes public modern-slavery disclosure and MSAT at Level 3. The signed statement is a disclosure record; a completed MSAT and an assessment score need separate evidence. No current score or completed assessment was located in the reviewed site files.
NHS modern-slavery procurement regulations took effect on 17 May 2026. Applicable supplier conditions should be checked for the actual procurement. The existence of a voluntary statement does not, by itself, fulfil every possible tender or assurance requirement.
Questions about the record.
For a specific enquiry, use the company contact route and identify the modern-slavery statement. The signed source contains the current policy and escalation wording. If a summary on this page or in the guide differs, the signed document should be read for the authoritative text.
